Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.
BACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expres...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3869847?pdf=render |
id |
doaj-c229c5345af04f6f8c0cb7d4c8122b30 |
---|---|
record_format |
Article |
spelling |
doaj-c229c5345af04f6f8c0cb7d4c8122b302020-11-24T21:45:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8454810.1371/journal.pone.0084548Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice.Xiongliang ZhangXiaoyu YanLiang ChengJiezhi DaiChunyang WangPei HanYimin ChaiBACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expression of angiogenic factors, which might contribute to the improvement of the diabetic wound healing. MATERIALS AND METHODS: 50 dB/db mice were employed and randomly assigned into five groups with 10 mice in each: group 1 (untreated cell), group 2 (PHD2 silenced cell), group 3 (L-mimosine treated cells), group 4 (nontargeting siRNA treated cells) and group 5 (sham control). Fibroblasts were cultivated from the dermis of mice in each group and treated with PHD2 targeting siRNA, L-mimosine and non-targeting siRNA respectively. A fraction of the fibroblasts were employed to verify the silencing rate of PHD2 after 48 hours. The autologous fibroblasts (treated and untreated) labeled with adenovirus-GFP were implanted around the wound (Φ6mm), which was created on the dorsum of each mouse. The status of wounds was recorded periodically. Ten days postoperatively, 3 mice from each group were sacrificed and wound tissues were harvested. Molecular biological examinations were performed to evaluate the expressions of cytokines. 28 days postoperatively, the remaining mice were sacrificed. Histological examinations were performed to evaluate the densities of GFP+ cells and capillaries. RESULTS: The expression of PHD2 reduced to 12.5%, and the expressions of HIF-1α and VEGFa increased significantly after PHD2 siRNA treatment. With the increasing expressions of HIF-1α and VEGFa, the time to wound closure in group 2 was less than 2 weeks. Increased numbers of GFP+ cells and capillaries were observed in group 2. CONCLUSION: PHD2 siRNA treatment not only increased the expression of HIF1α and VEGFa, but also improved the fibroblast proliferation. These effects might contribute to the improvement of the diabetic wound healing.http://europepmc.org/articles/PMC3869847?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiongliang Zhang Xiaoyu Yan Liang Cheng Jiezhi Dai Chunyang Wang Pei Han Yimin Chai |
spellingShingle |
Xiongliang Zhang Xiaoyu Yan Liang Cheng Jiezhi Dai Chunyang Wang Pei Han Yimin Chai Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. PLoS ONE |
author_facet |
Xiongliang Zhang Xiaoyu Yan Liang Cheng Jiezhi Dai Chunyang Wang Pei Han Yimin Chai |
author_sort |
Xiongliang Zhang |
title |
Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. |
title_short |
Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. |
title_full |
Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. |
title_fullStr |
Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. |
title_full_unstemmed |
Wound healing improvement with PHD-2 silenced fibroblasts in diabetic mice. |
title_sort |
wound healing improvement with phd-2 silenced fibroblasts in diabetic mice. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
BACKGROUND: Hypoxia-inducible factor 1α is the central regulator of the hypoxia-induced response which results in the up-regulation of angiogenic factors. Its activity is under precise regulation of prolyl-hydroxylase domain 2. We hypothesized that PHD2 silenced fibroblasts would increase the expression of angiogenic factors, which might contribute to the improvement of the diabetic wound healing. MATERIALS AND METHODS: 50 dB/db mice were employed and randomly assigned into five groups with 10 mice in each: group 1 (untreated cell), group 2 (PHD2 silenced cell), group 3 (L-mimosine treated cells), group 4 (nontargeting siRNA treated cells) and group 5 (sham control). Fibroblasts were cultivated from the dermis of mice in each group and treated with PHD2 targeting siRNA, L-mimosine and non-targeting siRNA respectively. A fraction of the fibroblasts were employed to verify the silencing rate of PHD2 after 48 hours. The autologous fibroblasts (treated and untreated) labeled with adenovirus-GFP were implanted around the wound (Φ6mm), which was created on the dorsum of each mouse. The status of wounds was recorded periodically. Ten days postoperatively, 3 mice from each group were sacrificed and wound tissues were harvested. Molecular biological examinations were performed to evaluate the expressions of cytokines. 28 days postoperatively, the remaining mice were sacrificed. Histological examinations were performed to evaluate the densities of GFP+ cells and capillaries. RESULTS: The expression of PHD2 reduced to 12.5%, and the expressions of HIF-1α and VEGFa increased significantly after PHD2 siRNA treatment. With the increasing expressions of HIF-1α and VEGFa, the time to wound closure in group 2 was less than 2 weeks. Increased numbers of GFP+ cells and capillaries were observed in group 2. CONCLUSION: PHD2 siRNA treatment not only increased the expression of HIF1α and VEGFa, but also improved the fibroblast proliferation. These effects might contribute to the improvement of the diabetic wound healing. |
url |
http://europepmc.org/articles/PMC3869847?pdf=render |
work_keys_str_mv |
AT xiongliangzhang woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice AT xiaoyuyan woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice AT liangcheng woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice AT jiezhidai woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice AT chunyangwang woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice AT peihan woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice AT yiminchai woundhealingimprovementwithphd2silencedfibroblastsindiabeticmice |
_version_ |
1725906557093281792 |